Drug Discovery for Nervous System Disorders (R01) (Discontinued)

Drug Discovery for Nervous System Disorders is sponsored by National Institute on Drug Abuse (NIDA) and National Institute on Aging (NIA) (among others). This highlighted topic aims to accelerate drug discovery for nervous system disorders, including substance use disorders and Alzheimer's disease. It encourages the application of AI and machine learning to accelerate the discovery and optimization of novel lead molecules.

Drug Discovery for Nervous System Disorders is sponsored by National Institutes of Health (NIH) - National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), National Institute on Aging (NIA), National Eye Institute (NEI). This highlighted topic encourages the discovery of novel therapeutics, including small molecules and biologics, for nervous system disorders.

Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) (PAR 27 081) is sponsored by National Institutes of Health (NIH). This funding opportunity supports the discovery of in vivo chemical probes for the nervous system, which could have implications for understanding and treating neurological disorders.